Suppr超能文献

CCN蛋白在纤维化疾病中的病理活性分析:肝纤维化

Analysis of Pathological Activities of CCN Proteins in Fibrotic Diseases: Liver Fibrosis.

作者信息

Chen Li, Brigstock David R

机构信息

The Research Institute at Nationwide Children's Hospital, Research Building 2, 700 Children's Drive, Columbus, OH, 43205, USA.

Molecular, Cellular, and Developmental Biology Program, The Ohio State University, Columbus, OH, 43212, USA.

出版信息

Methods Mol Biol. 2017;1489:445-463. doi: 10.1007/978-1-4939-6430-7_37.

Abstract

Hepatic fibrosis is a complex pathology arising from chronic injury. Pathological features are dominated by the excessive production of extracellular matrix proteins, particularly collagens which are deposited as insoluble scar material that can compromise tissue function. Fibrosis in the liver can often be assessed by staining for collagen in tissue sections and this is an approach that is widely used for grading of fibrosis in human biopsies. However, the recognition of the molecular components that drive fibrosis, including CCN proteins, and the involvement of hepatic stellate cells (HSC) as the principal collagen-producing cells in fibrosing liver, has resulted in a wide variety of molecular and cellular approaches to study the pathogenesis of fibrosis both in vivo and in vitro.

摘要

肝纤维化是一种由慢性损伤引起的复杂病理状态。其病理特征主要表现为细胞外基质蛋白过度产生,尤其是胶原蛋白,这些胶原蛋白以不溶性瘢痕物质的形式沉积,会损害组织功能。肝脏纤维化通常可通过对组织切片中的胶原蛋白进行染色来评估,这种方法广泛用于人类活检中纤维化的分级。然而,对驱动纤维化的分子成分(包括CCN蛋白)的认识,以及肝星状细胞(HSC)作为纤维化肝脏中主要胶原蛋白产生细胞的参与,导致了多种分子和细胞方法来研究体内和体外纤维化的发病机制。

相似文献

本文引用的文献

2
Hepatic fibrosis: Concept to treatment.肝纤维化:从概念到治疗。
J Hepatol. 2015 Apr;62(1 Suppl):S15-24. doi: 10.1016/j.jhep.2015.02.039.
9
Hepatic fibrosis -- overview.肝纤维化——概述。
Toxicology. 2008 Dec 30;254(3):120-9. doi: 10.1016/j.tox.2008.06.013. Epub 2008 Jul 10.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验